Intuitive Surgical has received FDA clearance for cardiac procedures using the da Vinci 5 surgical robot, according to a Jan. 26 report from Mass Device.
The new cardiac clearances cover mitral valve repair, internal mammary artery mobilization for cardiac revascularization, patent foramen ovale closure, atrial septal defect repair, left atrial appendage closure/occlusion, atrial myxoma excision, mitral valve replacement, tricuspid valve repair and epicardial pacing lead placement.
Intuitive’s portfolio of non-Force Feedback instruments all earned initial FDA approvals. The company will also look to receive cardiac clearances for its Force Feedback portfolio.
Surgeons used the da Vinci system for about 17,000 cardiac procedures worldwide in 2025, according to Intuitive Surgical’s CFO Jamie Samath.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
